Description:
This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2258526 and the solicitation is issued as a Request for Quotes (RFQ).
This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-03, January 17, 2025.
The North American Industry Classification System (NAICS) code for this procurement is NAICS: 325414 – Biological Product (Except Diagnostic) Manufacturing with a Size Standard of 1250 employees. The requirement is being competed full and open competition, un-restricted, and without a small business set-aside.
Vaccine Research Center (VRC) at the National Institutes of Health (NIH) was established to facilitate research in vaccine development. The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases. The VRC seeks to obtain Lab and blood collection supplies. These are necessary supplies to support ongoing research experiments.
Specifications of requirement:
LUMITRAC™ 600 plates Case of 40
Catalog# 82050-724
Quantity: 2 Cases of 40/Case
VWR Micro Centrifuge Tube with Flat Screw-Cap
Catalog# 16466-042
Quantity: 5 packs of 500/Pack
Microtube (0.5 mL)
Catalog# 76417-236
Quantity: 1 Case of 5000/Case
Magnesium acetate, 2M, 250 mL each Supplier Rigaku -1008335 (restricted product;
can only be purchased by approved Shipping Accounts; email Regulatory_Affairs@vwr.com
Catalog# 101443-722
Quantity: 3 Per each
Finntip™ 50
Catalog# 14224-024
Quantity:10 cases of 3840
Brilliant Violet 605™ anti-mouse IgD Antibody
Catalog# 10761-002
Quantity: 4 per each
Brilliant Violet 510™ anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody
Catalog# 10759-188
Quantity: 4 per each.
Brilliant Violet 510™ anti-mouse F4/80 Antibody
Catalog# 10757-014
Quantity: 3 per each.
Brilliant Violet 510™ anti-mouse CD8a Antibody
Catalog# 10756-702
Quantity: 3 per each
Brilliant Violet 510™ anti-mouse CD4 Antibody
Catalog# 10019-044
Quantity: 3 Per each
Brilliant Violet 421™ anti-mouse CD19 Antibody
Catalog# 115538-BL
Quantity: 4 Per each
Brilliant Violet 711™ anti-mouse CD138 (Syndecan-1) Antibody
Catalog# 10757-304
Quantity: 4 Per each
PerCP/Cyanine5.5 anti-mouse CD95 (Fas) Antibody
Catalog# 76013-342
Quantity: 2 Per each
HSD5000 ScreenTape
Catalog# 76645-084
Quantity: 8 Per each
HSD5000 Reagents
Catalog# 76645-492
Quantity: 8 Per each
SureBlue™ TMB 1-Component Microwell Peroxidase Substrate
Catalog# 95059-286
Quantity: 8 Per each
Quality economy brand luer slip syringes with attached needle, air-tite
Catalog# 76124-672
Quantity: 5 boxes of 100/Box
Single use syringe/Bd precision glide needles combinations, sterile
Catalog# BD309571
Quantity: 1 Case of 800/Case
Delivery date: Within approximately 10 days.
Place of Performance: NIH, NIAID, Bethesda, MD 20814
FOB: Destination
The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following: technical capability to meet the requirements and price.
By submitting a quote in response to this solicitation, vendor is accepting the following terms and conditions:
The following FAR provisions apply to this acquisition:
FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (MAY 2024)
FAR 52.204-7 System for Award Management (OCT 2018)
(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)
FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)
52.204–26 Covered Telecommunications Equipment or Services-Representation
(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26
The following FAR contract clauses apply to this acquisition:
FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2023)
FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (NOV 2024)
*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.
FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)
FAR 52.204-13 System for Award Management Maintenance (OCT 2018)
FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)
HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015)
FAR 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm
By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).
Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.
Submission shall be received not later than Monday, 05/12/2025 at 10:00 am EST
All quotations and required documents must be submitted via the NIAID electronic SIMPLIFIED ACQUISITION SUBMISSION SYSTEM (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit a quotation. Instructions on how to register / submit quotes are included on the website. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency.
